ARDX vs MTD · rev $215.3M vs P/E 27, rev $1.97B
Ardelyx Inc (ARDX) versus Mettler-Toledo International Inc (MTD) — a side-by-side from cached financials, not a winner call.
Ardelyx Inc (ARDX) is a biotechnology company listed on US.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
Latest reported ARDX revenue for 2026-06-30 was $215.3M. Net income was -$54.3M. ARDX currently screens at market cap $1.37B.
Latest reported MTD revenue for 2026-06-30 was $1.97B. Net income was $402.4M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
ARDX currently screens at market cap $1.37B. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Not investment advice. Open the ARDX and MTD stock pages for the full models.
Not investment advice.